The Global Disposable Ureteroscope Market was valued at USD 310.1 million in 2025 and is estimated to grow at a CAGR of 15.6% to reach USD 1.3 billion in 2035.
The market expansion is influenced by the rising incidence of urolithiasis, continuous advancements in imaging and endoscopic technologies, and growing preference for minimally invasive urological procedures. Increasing adoption across ambulatory surgical centers is also reinforcing demand, as healthcare providers prioritize faster turnaround times and reduced infection risks. Disposable ureteroscopes are single-use endoscopic instruments designed for visualization and treatment of ureter and kidney conditions, offering flexible or semi-rigid configurations with integrated imaging systems. These devices support accurate diagnosis and management of kidney stones, ureteral strictures, and urinary tract tumors while significantly reducing cross-contamination risks and eliminating the need for reprocessing and sterilization. Their operational efficiency and consistent performance are making them increasingly preferred in modern urology practices. In addition, rising healthcare expenditure and expanding access to advanced surgical care in emerging regions are further supporting adoption. The growing shift toward value-based healthcare models is also encouraging the use of cost-efficient single-use devices, contributing to long-term market penetration.
The flexible ureteroscope segment held a share of 81.9% in 2025, supported by strong clinical adoption and superior maneuverability in minimally invasive urological procedures. This segment’s leadership is attributed to its ability to provide enhanced navigation and visualization within complex renal structures, making it highly suitable for procedures such as ureteroscopy and retrograde intrarenal surgery. Increasing emphasis on infection control, procedural consistency, and operational efficiency is further driving preference for single-use flexible ureteroscopes across hospitals and ambulatory surgical environments.
The urolithiasis segment reached USD 145.6 million in 2025. Urolithiasis, commonly known as kidney stone disease, affects a significant global population and remains a leading cause of urological interventions. The condition continues to rise due to increasing prevalence of obesity, diabetes, and lifestyle-related dietary changes, which collectively contribute to higher stone formation rates. This growing disease burden is accelerating demand for effective diagnostic and therapeutic solutions. Disposable ureteroscopes are widely utilized in this segment due to their high-definition imaging capabilities, enabling precise detection and treatment of stones within the urinary tract and improving clinical outcomes.
North America Disposable Ureteroscope Market captured 38.7% share in 2025. The region’s dominance is supported by a high prevalence of urological conditions such as kidney stones, urinary tract infections, ureteral strictures, and renal cancers. Increasing procedural volumes across hospitals and ambulatory surgical centers are further strengthening demand, as healthcare systems continue to rely on advanced endoscopic solutions for efficient and minimally invasive treatment delivery.
Key players operating in the Global Disposable Ureteroscope Market include Ambu, Becton, Dickinson and Company, Boston Scientific, Coloplast, Cook Medical, Dornier MedTech, Karl Storz, NeoScope, OLYMPUS, OPCOM Medical, OTU Medical, Richard Wolf, STERIS, and Zhuhai Pusen Medical Technology. Companies in the disposable ureteroscope market are actively focusing on product innovation to enhance imaging quality, flexibility, and ergonomic design for improved procedural efficiency. Many manufacturers are investing in advanced digital visualization technologies and integrated imaging systems to support more accurate diagnosis and treatment outcomes. Strategic collaborations with hospitals and ambulatory surgical centers are being used to expand product adoption and strengthen distribution networks. Firms are also prioritizing cost optimization strategies to make single-use devices more accessible across diverse healthcare settings. Expansion into emerging healthcare markets is supporting revenue diversification and broader geographic reach.
This product will be delivered within 2-4 business days.
The market expansion is influenced by the rising incidence of urolithiasis, continuous advancements in imaging and endoscopic technologies, and growing preference for minimally invasive urological procedures. Increasing adoption across ambulatory surgical centers is also reinforcing demand, as healthcare providers prioritize faster turnaround times and reduced infection risks. Disposable ureteroscopes are single-use endoscopic instruments designed for visualization and treatment of ureter and kidney conditions, offering flexible or semi-rigid configurations with integrated imaging systems. These devices support accurate diagnosis and management of kidney stones, ureteral strictures, and urinary tract tumors while significantly reducing cross-contamination risks and eliminating the need for reprocessing and sterilization. Their operational efficiency and consistent performance are making them increasingly preferred in modern urology practices. In addition, rising healthcare expenditure and expanding access to advanced surgical care in emerging regions are further supporting adoption. The growing shift toward value-based healthcare models is also encouraging the use of cost-efficient single-use devices, contributing to long-term market penetration.
The flexible ureteroscope segment held a share of 81.9% in 2025, supported by strong clinical adoption and superior maneuverability in minimally invasive urological procedures. This segment’s leadership is attributed to its ability to provide enhanced navigation and visualization within complex renal structures, making it highly suitable for procedures such as ureteroscopy and retrograde intrarenal surgery. Increasing emphasis on infection control, procedural consistency, and operational efficiency is further driving preference for single-use flexible ureteroscopes across hospitals and ambulatory surgical environments.
The urolithiasis segment reached USD 145.6 million in 2025. Urolithiasis, commonly known as kidney stone disease, affects a significant global population and remains a leading cause of urological interventions. The condition continues to rise due to increasing prevalence of obesity, diabetes, and lifestyle-related dietary changes, which collectively contribute to higher stone formation rates. This growing disease burden is accelerating demand for effective diagnostic and therapeutic solutions. Disposable ureteroscopes are widely utilized in this segment due to their high-definition imaging capabilities, enabling precise detection and treatment of stones within the urinary tract and improving clinical outcomes.
North America Disposable Ureteroscope Market captured 38.7% share in 2025. The region’s dominance is supported by a high prevalence of urological conditions such as kidney stones, urinary tract infections, ureteral strictures, and renal cancers. Increasing procedural volumes across hospitals and ambulatory surgical centers are further strengthening demand, as healthcare systems continue to rely on advanced endoscopic solutions for efficient and minimally invasive treatment delivery.
Key players operating in the Global Disposable Ureteroscope Market include Ambu, Becton, Dickinson and Company, Boston Scientific, Coloplast, Cook Medical, Dornier MedTech, Karl Storz, NeoScope, OLYMPUS, OPCOM Medical, OTU Medical, Richard Wolf, STERIS, and Zhuhai Pusen Medical Technology. Companies in the disposable ureteroscope market are actively focusing on product innovation to enhance imaging quality, flexibility, and ergonomic design for improved procedural efficiency. Many manufacturers are investing in advanced digital visualization technologies and integrated imaging systems to support more accurate diagnosis and treatment outcomes. Strategic collaborations with hospitals and ambulatory surgical centers are being used to expand product adoption and strengthen distribution networks. Firms are also prioritizing cost optimization strategies to make single-use devices more accessible across diverse healthcare settings. Expansion into emerging healthcare markets is supporting revenue diversification and broader geographic reach.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Product, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Application, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies profiled in this Disposable Ureteroscope market report include:- Ambu
- Becton, Dickinson and Company
- Boston Scientific
- Coloplast
- Cook Medical
- Dornier MedTech
- Karl Storz
- NeoScope
- OLYMPUS
- OPCOM Medical
- OTU Medical
- Richard Wolf
- STERIS
- Zhuhai Pusen Medical Technology
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | April 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 310.1 Million |
| Forecasted Market Value ( USD | $ 1300 Million |
| Compound Annual Growth Rate | 15.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
